Work

Phase 2 trial of concurrent 5‐fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity‐modulated radiation therapy for locally advanced head and neck cancer

FWCI: 4.538
Cites: 28
Cited by: 37
Related to: 10